Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

An expanding body of evidence continues to build on the role of platelets as initial actors in
the development of atherosclerotic lesions. Platelets bind to leukocytes and endothelial …

OBJECTIVE Sirtuins (SIRTs) are NAD+-dependent deacetylases that regulate metabolism
and life span. We used peripheral blood mononuclear cells (PBMCs) to determine ex vivo …

Historically, revascularization of ischemic tissue was believed to occur through the migration
and proliferation of endothelial cells in nearby tissues; however, evidence accumulated in …

In the last 10 years an increasing interest has been devoted to the study of endothelial
progenitor cells (EPCs), a subtype of immature cells involved in endothelial repair and …

The cardiovascular and haematopoietic systems have fundamental inter-relationships
during development, as well as in health and disease of the adult organism. Although …

Atherosclerotic diseases are responsible for a significant part of morbidity and mortality in
western countries. According to the classical views, atherosclerotic lesions develop as the …

Objective—Endothelial progenitor cells (EPCs) participate in vascular homeostasis and
angiogenesis. The aim of the present study was to explore EPC number and function in …

The discovery of endothelial progenitor cells (EPCs) in human peripheral blood advanced
the field of cell-based therapeutics for many pathological conditions. Despite the lack of …

Aims/hypothesis Type 1 diabetes is associated with premature arterial disease. Bone-
marrow derived, circulating endothelial progenitor cells (EPCs) are believed to contribute to …